Danny Sullivan

XAMPP is used by many WordPress administrators to set up WordPress environments. While there are many different case uses, some of the most common use cases are to set up a staging, development or testing environment. As a highly configurable environment, XAMPP offers many advantages, including the…

Rather than study animals that age quickly, Prof Steven Austad believes animals that age slowly may hold the answers to human longevity.

Longevity biotech focused venture capital firm moves into the decentralized Web3 ecosystem with new partnership.

Juvenescence-backed MDI Therapeutics gears up with $9m for clinical trials of serpin-based fibrosis therapy.

Morphoceuticals has “zero doubt” that regeneration research conducted in frogs can be recreated in humans – it’s just a matter of time.

Longevity company Vitalunga to develop mitophagy-activating drugs that rejuvenate cells, and extend lifespan and healthspan in worm models.

First Longevity aims to accelerate growth in the longevity sector with dedicated platform for accredited investors.

Investment arm of world’s most valuable company leads new $35 million investment in AI drug discovery firm Insilico Medicine.

Top investor talks longevity investment, optimism on SPAC deal, and light at the end of the tunnel for the biotech market.

Regenerative Medicine Foundation highlights the need for patient advocacy in longevity and calls for treatments to be made available to all.

Mehmood Khan says funding scientific research on aging is a key strategy but investments in longevity companies will also be announced soon.

Maximon CSO Elisabeth Roider talks clinics, diagnostics, and why longevity is about much more than drug development.

Biolytica CEO on the importance of using combined health data and AI in longevity to enable personalised and preventive health to flourish.

EMulate Therapeutics uses magnetic field technology to emulate drug effects in humans and animal models without using chemicals.

AmyriAD CEO tempers expectations on lecanemab and explains how layering therapies may help “turn the clock” back further for Alzheimer’s.

The latest longevity investment news and updates from our investment news desk. Featuring: CARMAT, Longeveron, NeuroSense and Capsida.

Longevity investment bulletin: Mitobridge, Fractyl Health, Insilico Medicine, Huma Therapeutics, Rubedo Life Sciences and more.

Longevity investment bulletin featuring Cerevance, Frequency Therapeutics, Heartseed, Life Biosciences and NeuroSense.

Casma Therapeutics has built an autophagy-inducing platform for targeted degradation across a host of age-related diseases.

AKL Therapeutics combines synthesized plant metabolites to create promising oral osteoarthritis treatment.